| Michael J Qualey, MD | |
|
1000 4th St Sw, Mason City, IA 50401-2800 | |
| (641) 422-7000 | |
| Not Available |
| Full Name | Michael J Qualey |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 29 Years |
| Location | 1000 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629015607 | NPI | - | NPPES |
| 0203521 | Medicaid | IA | |
| 14604 | Other | IA | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 33174 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
Researchers at The University of Nottingham have got more bad news for smokers. Not only does it cause cancer, heart attacks and strokes but smokers will also lose more muscle mass in old age than a non-smoker. The effect of this predisposes smokers to an accelerated decline in physical function and loss of independence.
ULURU Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Researchers at the University of Southampton have shed new light on why and how a new class of drug is effective at fighting off leukaemia.
Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.
› Verified 8 days ago
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
Researchers at The University of Nottingham have got more bad news for smokers. Not only does it cause cancer, heart attacks and strokes but smokers will also lose more muscle mass in old age than a non-smoker. The effect of this predisposes smokers to an accelerated decline in physical function and loss of independence.
ULURU Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Researchers at the University of Southampton have shed new light on why and how a new class of drug is effective at fighting off leukaemia.
Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.
› Verified 8 days ago
| Entity Name | North Iowa Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649223702 PECOS PAC ID: 2769372580 Enrollment ID: O20040316001446 |
News Archive
Researchers at The University of Nottingham have got more bad news for smokers. Not only does it cause cancer, heart attacks and strokes but smokers will also lose more muscle mass in old age than a non-smoker. The effect of this predisposes smokers to an accelerated decline in physical function and loss of independence.
ULURU Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Researchers at the University of Southampton have shed new light on why and how a new class of drug is effective at fighting off leukaemia.
Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.
› Verified 8 days ago
| Entity Name | Mhc Anesthesia Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639244270 PECOS PAC ID: 2860383296 Enrollment ID: O20040323001946 |
News Archive
Researchers at The University of Nottingham have got more bad news for smokers. Not only does it cause cancer, heart attacks and strokes but smokers will also lose more muscle mass in old age than a non-smoker. The effect of this predisposes smokers to an accelerated decline in physical function and loss of independence.
ULURU Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Researchers at the University of Southampton have shed new light on why and how a new class of drug is effective at fighting off leukaemia.
Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Qualey, MD 1410 6th St Sw, Mason City, IA 50401-4818 Ph: (641) 424-6704 | Michael J Qualey, MD 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 422-7000 |
News Archive
Researchers at The University of Nottingham have got more bad news for smokers. Not only does it cause cancer, heart attacks and strokes but smokers will also lose more muscle mass in old age than a non-smoker. The effect of this predisposes smokers to an accelerated decline in physical function and loss of independence.
ULURU Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Researchers at the University of Southampton have shed new light on why and how a new class of drug is effective at fighting off leukaemia.
Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.
› Verified 8 days ago
Dr. Meghana Roy, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1410 6th St Sw, Mason City, IA 50401 Phone: 641-424-6704 | |
Donald L Kropf, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-422-7000 | |
Dr. Shari M Brandli, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7000 | |
Timothy J Cross, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-422-7000 | |
Dr. Wade A Sewell, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-422-7000 | |
Benjamin Mathews, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7000 | |
Sheela Ahari, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-422-7000 |